Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button


Home > News > MIV Therapeutics Drug-Eluting Stent Coating

September 24th, 2003

MIV Therapeutics Drug-Eluting Stent Coating

MIV Therapeutics Inc. has received a mid-point milestone interim progress report from the University of British Columbia (UBC) on the development of its proprietary HAp (hydroxyapatite) multi-layer coating with drug-eluting capabilities. "The research work on multi-layer coating applications is progressing on schedule. Our deposition methods have shown promising results with respect to nano-porosity and drug encapsulation for drug-eluting stents."

MIV Therapeutics

Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press


UTA researcher to build internal nanotechnology device to simplify blood sugar testing: Medical technologies December 1st, 2015

Tiny octopods catalyze bright ideas: Rice-led study shows plasmonic sensors and catalysts need not be mutually exclusive November 30th, 2015

Nanoparticles simplify DNA identification and quantification November 27th, 2015

Scientists 'see' detailed make-up of deadly toxin for the first time: Exciting advance provides hope for developing novel potential method of treating pneumococcal diseases such as bacterial pneumonia, meningitis and septicaemia November 25th, 2015

The latest news from around the world, FREE

  Premium Products
Only the news you want to read!
 Learn More
University Technology Transfer & Patents
 Learn More
Full-service, expert consulting
 Learn More

Nanotechnology Now Featured Books


The Hunger Project

Car Brands
Buy website traffic